Low molecular weight peptides in gastroenterology: therapeutic potential
- Authors: Kovaleva V.N.1, Malevanny A.E.2, Krasovskaya M.A.2, Mordvintsev D.Y.1
-
Affiliations:
- Research Institute of Functional Nutrition
- Clinic of Holistic Medicine and Diagnostics «Adaptogenzz»
- Issue: Vol 36, No 12 (2025)
- Pages: 58-61
- Section: Pharmacology
- URL: https://journals.rcsi.science/0236-3054/article/view/365678
- DOI: https://doi.org/10.29296/25877305-2025-12-12
- ID: 365678
Cite item
Abstract
To evaluate the efficacy of peptide hydrolysates of animal and fish origin in reducing the severity of symptoms in patients with chronic diseases of the digestive system. Patients with chronic gastritis, chronic pancreatitis, gastroesophageal reflux disease, chronic constipation, intestinal malabsorption, multiple intestinal polyposis participated in the study. The prevalence of symptoms of the described diseases among participants was assessed before treatment and during one year of peptide hydrolysate supplementation. By the end of the course of monotherapy with peptide hydrolysates, the prevalence of all analysed symptoms of chronic digestive diseases was significantly lower compared to the pre-test results. The clinical effect in the majority of patients was achieved within the first 3–6 months of treatment.
About the authors
V. N. Kovaleva
Research Institute of Functional Nutrition
Author for correspondence.
Email: info@nutrition-institute.ru
Russian Federation, Moscow
A. E. Malevanny
Clinic of Holistic Medicine and Diagnostics «Adaptogenzz»
Email: info@nutrition-institute.ru
Russian Federation, Moscow
M. A. Krasovskaya
Clinic of Holistic Medicine and Diagnostics «Adaptogenzz»
Email: info@nutrition-institute.ru
Russian Federation, Moscow
D. Yu. Mordvintsev
Research Institute of Functional Nutrition
Email: info@nutrition-institute.ru
Candidate of Chemical Sciences
Russian Federation, MoscowReferences
- Bai Z., Wang H., Shen C. et al. The global, regional, and national patterns of change in the burden of nonmalignant upper gastrointestinal diseases from 1990 to 2019 and the forecast for the next decade. Int J Surg. 2025; 111 (1): 80–92. doi: 10.1097/JS9.0000000000001902
- Niv Y., Hazazi R. Helicobacter pylori recurrence in developed and developing countries: meta-analysis of 13C-urea breath test follow-up after eradication. Helicobacter. 2008; 13 (1): 56–61. doi: 10.1111/j.1523-5378.2008.00571.x
- Xue Y., Zhou L.Y., Lu H.P. et al. Recurrence of Helicobacter pylori infection: incidence and influential factors. Chin Med J (Engl). 2019; 132 (7): 765–71. doi: 10.1097/CM9.0000000000000146
- Kliewer K.L., Murray-Petzold C., Collins M.H. et al. Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Gastroenterol Hepatol. 2023; 8 (9): 803–15. doi: 10.1016/S2468-1253(23)00145-0
- Сапожников В.Г., Воробьева А.В. Клинические проявления хронических болезней органов пищеварения. Вестник новых медицинских технологий. 2015; 22 (1): 23–7 [Sapozhnikov V.G., Vorobiyova A.V. The clinical manifestations of chronic diseases of the digestive system in children. Journal of New Medical Technologies. 2015; 22 (1): 23–7 (in Russ.)]. doi: 10.12737/9071
- Dickerson J.F., Salas S.B., Donald J. et al. Economic burden of acute gastroenteritis among members of integrated healthcare delivery system, United States, 2014–2016. Emerg Infect Dis. 2024; 30 (5): 968–73. doi: 10.3201/eid3005.230356
- Manninen A.H. Protein hydrolysates in sports and exercise: a brief review. J Sports Sci Med. 2004; 3 (2): 60–3.
- Kim S.K., Mendis E. Bioactive compounds from marine processing byproducts – a review. Food Research International. 2006; 39 (4): 383–93. doi: 10.1016/j.foodres.2005.10.010
- Boldyrev A.A., Aldini G., Derave W. Physiology and pathophysiology of carnosine. Physiol Rev. 2013; 93 (4): 1803–45. doi: 10.1152/physrev.00039.2012
- Silk D.B. The role of dietary peptides in human nutrition. Annu Rev Nutr. 2009; 29: 183–201.
- Kim S.K., Wijesekara I. Bioactive peptides from marine sources: a review. J Funct Foods. 2010; 2 (3): 225–35.
- Grimble G.K. The significance of peptides in clinical nutrition. Annu Rev Nutr. 1994; 14: 419–47. doi: 10.1146/annurev.nu.14.070194.002223
- Silk D.B.A. Peptide absorption. Gut. 1994; 35 (5): 577–9.
- Lindergaard M. et al. Enzymatic Hydrolysis of Proteins. Journal of Agricultural and Food Chemistry. 2022; 70 (1): 1–15.
- Kim K.J. et al. Effects of Fish Protein Hydrolysate on Constipation in Rats. J Funct Foods. 2017; 32: 122–9.
Supplementary files
